Target Name: MIR4739
NCBI ID: G100616170
Other Name(s): hsa-mir-4739 | hsa-miR-4739 | mir-4739 | MicroRNA 4739 | microRNA 4739 | Mir-4739

MIR4739: A Potential Drug Target and Biomarker

MIR4739 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is a key regulator of the immune response and has been shown to play a role in a variety of diseases, including cancer, autoimmune disorders, and neurodegenerative diseases.

MIR4739 is a member of the MIR470 family of non-coding RNAs, which are known for their ability to interact with protein coding genes and regulate gene expression. It is expressed in a variety of tissues and cells, including immune cells, neurons, and tissues.

One of the most promising aspects of MIR4739 is its potential as a drug target. MIR4739 has been shown to play a role in the regulation of immune cell function, which makes it a potential target for drugs that are designed to modulate the immune response. For example, studies have shown that MIR4739 can be inhibited by drugs that are used to treat cancer, and that this can lead to an improvement in the immune response to the disease.

In addition to its potential as a drug target, MIR4739 has also been shown to be a potential biomarker. Its expression has been shown to be regulated in a variety of diseases, including cancer, and this regulation may be a potential target for diagnostic tests. For example, studies have shown that MIR4739 can be used as a biomarker for cancer, and that this can be detected using techniques such as qRT-PCR and western blotting.

Another promising aspect of MIR4739 is its ability to modulate the immune response in a variety of ways. For example, studies have shown that MIR4739 can inhibit the production of antibodies by immune cells, which can lead to an improvement in the immune response to a variety of infections. In addition, MIR4739 has been shown to promote the elimination of damaged cells from the immune system, which can lead to a stronger immune response to cancer.

Overall, MIR4739 is a promising molecule that has the potential to be a drug target and biomarker. Its ability to modulate the immune response and its expression in a variety of tissues and cells make it a promising target for drugs that are designed to treat a variety of diseases. Further research is needed to fully understand the role of MIR4739 in the immune system and its potential as a drug and biomarker.

Protein Name: MicroRNA 4739

More Common Targets

MIR4740 | MIR4741 | MIR4742 | MIR4745 | MIR4746 | MIR4747 | MIR4749 | MIR4750 | MIR4751 | MIR4752 | MIR4753 | MIR4754 | MIR4755 | MIR4756 | MIR4757 | MIR4758 | MIR4759 | MIR4760 | MIR4761 | MIR4762 | MIR4763 | MIR4764 | MIR4765 | MIR4766 | MIR4767 | MIR4768 | MIR4769 | MIR4770 | MIR4771-1 | MIR4771-2 | MIR4772 | MIR4773-1 | MIR4773-2 | MIR4774 | MIR4775 | MIR4776-1 | MIR4776-2 | MIR4777 | MIR4778 | MIR4779 | MIR4780 | MIR4781 | MIR4782 | MIR4783 | MIR4784 | MIR4785 | MIR4786 | MIR4787 | MIR4789 | MIR4790 | MIR4791 | MIR4793 | MIR4794 | MIR4795 | MIR4796 | MIR4797 | MIR4798 | MIR4799 | MIR4800 | MIR4802 | MIR4803 | MIR4804 | MIR483 | MIR484 | MIR485 | MIR486-1 | MIR486-2 | MIR487A | MIR487B | MIR488 | MIR489 | MIR490 | MIR491 | MIR492 | MIR493 | MIR494 | MIR495 | MIR496 | MIR497 | MIR497HG | MIR498 | MIR4999 | MIR499A | MIR499B | MIR5000 | MIR5001 | MIR5002 | MIR5003 | MIR5004 | MIR5006 | MIR5007 | MIR5008 | MIR5009 | MIR500A | MIR500B | MIR501 | MIR5010 | MIR5011 | MIR502 | MIR503